MICHELLE LOOK: Open Payments
NPI 1851402143 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$85,501 in 78 payments from 7 companies in 2025. Trend: 2023 $46,955 · 2024 $58,965 · 2025 $85,501
Speaker / faculty: $55,556Consulting: $23,843Travel & lodging: $5,084Food & beverage: $973Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 47 | $55,420 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $13,533 |
| Eli Lilly and Company | 5 | $11,888 |
| Novo Nordisk Inc | 12 | $4,592 |
| Rhythm Pharmaceuticals, Inc. | 1 | $30 |
| Intra-Sana Laboratories | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $19 |
Products named: ZEPBOUND, MOUNJARO, Wegovy, IMCIVREE, RELTONE 200 MG, APTIMA, Saxenda.
Industry payments across CA — which companies pay providers there.
